Currently out of the existing stock ratings of Michael Morabito, 16 are a BUY (94.12%), 1 are a HOLD (5.88%).

Michael Morabito

Work Performance Price Targets & Ratings Chart

Analyst Michael Morabito works at CHARDAN CAPITAL with a stock forecast success ratio of 40.28% fulfilled within 214.33 days on average.

Michael Morabito’s has documented 36 price targets and ratings displayed on 8 stocks. The coverage is on Healthcare, Industrials sectors.

Most recent stock forecast was given on AXLA, Axcella Health at 02-Nov-2022.

Wall Street Analyst Michael Morabito

Analyst best performing recommendations are on MRTX (MIRATI THER).
The best stock recommendation documented was for MRTX (MIRATI THER) at 8/7/2020. The price target of $140 was fulfilled within 10 days with a profit of $11.12 (8.63%) receiving and performance score of 8.63.

Average potential price target upside

DRRX Durect ETN Eaton PLC MRTX Mirati Ther VKTX Viking Therapeutics AXLA Axcella Health AKRO Akero Therapeutics CWBR CohBar ICPT Intercept Pharmaceuticals

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

6 months 14 days ago

0/2 (0%)

$27.7 (101.47%)

Buy

27

$24.51 (984.34%)

32

6 months 14 days ago

0/2 (0%)

$25.57 (661.71%)

Buy

6

$5.02 (512.24%)

60

1 years 2 months 17 days ago

1/4 (25%)

$1.96 (48.51%)

34

Buy

80

$79.02 (8063.27%)

2 years 9 months 19 days ago

1/4 (25%)

$62.3 (351.98%)

343

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Michael Morabito?

On 2019

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?